QI ZHENG: Open Payments
NPI 1801375787 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,910 in 21 payments from 5 companies in 2025. Trend: 2023 $367 · 2024 $780 · 2025 $1,910
Food & beverage: $1,145Travel & lodging: $765
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 9 | $898 |
| Madrigal Pharmaceuticals | 7 | $480 |
| Gilead Sciences, Inc. | 3 | $302 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $124 |
| ABBVIE INC. | 1 | $106 |
Products named: AVEIR, REZDIFFRA, Epclusa, Vemlidy, XIFAXAN, RINVOQ.
Industry payments across NY — which companies pay providers there.
